Andy Pasternak, EVP and Chief Business Officer at Horizon Therapeutics Public Ltd Co (HZNP), sold 36,135 shares at $99.85 ($3.6M) on 2022-01-06, disclosed to the SEC on 2022-01-06.
Open-market sale of $3.6M HZNP by EVP and Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $101.84 | 21,710 | $2.2M | 60.6% |
| 2 | $97.30 | 500 | $49K | 1.3% |
| 3 | $98.33 | 700 | $69K | 1.9% |
| 4 | $99.85 | 6,438 | $643K | 17.6% |
| 5 | $99.85 | 6,438 | $643K | 17.6% |
| 6 | $100.23 | 349 |
| $35K |
| 1.0% |
| Total | $100.98 avg | 36,135 | $3.6M | 100% |
| Filing → |
| HZNP | SELL | 2022-07-29 | $801K | — | Filing → |
| HZNP | SELL | 2022-06-13 | $130K | — | Filing → |
| HZNP | SELL | 2022-02-18 | $249K | — | Filing → |